Health

US grants full approval to Moderna’s COVID-19 vaccine in adults

The US Food and Drug Administration on Monday gave full approval to Moderna’s COVID-19 vaccine for people age 18 and older, making it the second fully approved vaccine for the virus.

The Moderna vaccine has been authorized for emergency use in the United States since December 2020, and will now be sold under the brand name Spikevax. Pfizer and BioNTech’s COVID-19 shot using similar technology received full approval in the United States last year for people aged 16 and older after also first gaining emergency authorization.

For more coronavirus news, visit our dedicated page.

Nearly 75 million people have already received Moderna’s two-dose vaccine in the United States, according to data from the US Centers for Disease Control and Prevention.

“The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” Acting FDA Commissioner Dr. Janet Woodcock said in a statement.

Moderna’s vaccine is cleared for use in more than 70 countries, including Canada and the European Union.

Health

World News in Brief: Vaccine ‘patches’ trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation

Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots.

Health

No sign yet of H5N1 bird flu spreading between humans, says WHO chief

The H5N1 avian influenza virus has so far shown no signs of adapting to allow human to human transmission, the UN health agency said on Wednesday, urging continued surveillance.

Health

Patients in Rafah ‘afraid to seek services’, WHO reports

The World Health Organization (WHO) has taken “crucial steps” in the event of a large-scale Israeli military operation in Rafah, Dr. Ahmed Dahir, Team Lead of its office in Gaza, told UN News on Tuesday.